A Biotechnology company that collects comprehensive matrices of 19-channel quantitative EEG (qEEG) data—structured as time-series vectors across thousands of neurotypical and neurodiverse subjects (S_1, S_2, S_3 …)—aimed at discovering electromagnetic biomarkers to cluster distinct neurodevelopmental disorders like ADHD (the core foundation of adult psychopathology). The ultimate goal is to derive personalized, qEEG-informed tDCS and Neurofeedback protocols that enhance the quality of life for patients and their families via minimally invasive, precision interventions engineered to yield maximum efficacy with minimal side effects.